GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AMED Co Ltd (ROCO:7575) » Definitions » EBITDA Margin %

AMED Co (ROCO:7575) EBITDA Margin % : 22.08% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is AMED Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. AMED Co's EBITDA for the six months ended in Dec. 2023 was NT$91.0 Mil. AMED Co's Revenue for the six months ended in Dec. 2023 was NT$412.2 Mil. Therefore, AMED Co's EBITDA margin for the quarter that ended in Dec. 2023 was 22.08%.


AMED Co EBITDA Margin % Historical Data

The historical data trend for AMED Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AMED Co EBITDA Margin % Chart

AMED Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
16.77 18.40 19.00 21.02 20.60

AMED Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only 19.51 19.64 22.13 18.85 22.08

Competitive Comparison of AMED Co's EBITDA Margin %

For the Medical Instruments & Supplies subindustry, AMED Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AMED Co's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AMED Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where AMED Co's EBITDA Margin % falls into.



AMED Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

AMED Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=157.326/763.823
=20.60 %

AMED Co's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=91.044/412.248
=22.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AMED Co  (ROCO:7575) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


AMED Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of AMED Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


AMED Co (ROCO:7575) Business Description

Traded in Other Exchanges
N/A
Address
No. 14, Wuquan 7th Road, 4th Floor, Wugu District, New Taipei, TWN
AMED Co Ltd is fully committed to the research and development of UV photopolymerized hydrogels. It is a professional research and development and manufacturing company of wound dressing materials, providing proper wound care solutions, and marketing the product under the brand of Heli Dressing.

AMED Co (ROCO:7575) Headlines

No Headlines